Biologic therapy for psoriasis: A brief history, I

被引:0
|
作者
Tutrone, WD
Kagen, MH
Barbagallo, J
Weinberg, JM
机构
[1] St Lukes Roosevelt Hosp, Dept Dermatol, New York, NY USA
[2] Beth Israel Deaconess Med Ctr, Dept Dermatol, New York, NY 10003 USA
[3] Univ Vermont, Coll Med, Burlington, VT USA
[4] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[5] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源
CUTIS | 2001年 / 68卷 / 05期
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This article has been peer reviewed and approved by Michael Fisher, MID, Professor of Medicine, Albert Einstein College of Medicine. Review date: October 2001. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Albert Einstein College of Medicine and Quadrant HealthCom, Inc. The Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Albert Einstein College of Medicine designates this educational activity for a maximum of 1.0 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. This activity has been planned and produced in accordance with ACCME Essentials.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 50 条
  • [41] Effect of Biologic Therapy on Cardiovascular Risk in Patients With Psoriasis
    Gonzalez-Cantero, A.
    Sanchez-Moya, A. I.
    Perez-Hortet, C.
    ACTAS DERMO-SIFILIOGRAFICAS, 2019, 110 (08): : 685 - 686
  • [42] Considerations When Initiating Psoriasis Patients on Biologic Therapy
    Zeichner, Joshua A.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (05) : S11 - S14
  • [43] Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review
    Annika Smith
    Aidin Karahasan
    Deborah Yi
    Sanjay Yapabandara
    James Elhindi
    Pablo Fernandez-Penas
    Clara Chow
    Sarah Zaman
    Dermatology and Therapy, 2025, 15 (1) : 201 - 212
  • [44] Assessing the use of biologic therapy for psoriasis in Latin America
    Bravo, Francisco G.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (04) : 454 - 454
  • [45] The effect of weight on the efficacy of biologic therapy in patients with psoriasis
    Clark, Lily
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (03) : 443 - 446
  • [46] Superimposed linear psoriasis: low effectiveness of biologic therapy
    Colombo, L.
    Marconi, M.
    Mapelli, E. T. M.
    Crespi, E.
    Gualandri, L.
    Menni, S.
    Cerri, A.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2011, 146 (04): : 311 - 313
  • [47] A retrospective review of dupilumab and psoriasis biologic combination therapy
    Barry, Kelly
    Zancanaro, Pedro
    Casseres, Rachel
    Dumont, Nicole
    Rosmarin, David
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (04) : 438 - 439
  • [48] Biologic therapy increases Demodex density in psoriasis patients
    Aksoy, Hasan
    Kaksi, Sumeyye Altintas
    Gonullu, Oyku
    Kayiran, Melek Aslan
    Erdemir, Vefa A.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (09) : 1193 - 1199
  • [49] Goeckerman treatment for remission of psoriasis refractory to biologic therapy
    Serrao, Rocco
    Davis, Mark D. P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (02) : 348 - 349
  • [50] Recent history of systemic or biologic therapy does not appear to adversely affect adalimumab efficacy and safety in psoriasis
    Langley, Richard G.
    Leonardi, Craig
    Toth, Darryl
    Okun, Martin M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1820 - 1820